The effects of a smoking cessation intervention on 14.5-year mortality - A randomized clinical trial

被引:893
作者
Anthonisen, NR
Skeans, MA
Wise, RA
Manfreda, J
Kanner, RE
Connett, JE
机构
[1] Univ Minnesota, Minneapolis, MN USA
[2] Johns Hopkins Univ, Baltimore, MD USA
[3] Univ Utah, Salt Lake City, UT USA
[4] Univ Manitoba, Winnipeg, MB, Canada
关键词
D O I
10.7326/0003-4819-142-4-200502150-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Randomized clinical trials have not yet demonstrated the mortality benefit of smoking cessation. Objective: To assess the long-term effect on mortality of a randomly applied smoking cessation program. Design: The Lung Health Study was a randomized clinical trial of smoking cessation. Special intervention participants received the smoking intervention program and were compared with usual care participants. Vital status was followed up to 14.5 years. Setting: 10 clinical centers in the United States and Canada. Patients: 5887 middle-aged volunteers with asymptomatic airway obstruction. Measurements: All-cause mortality and mortality due to cardiovascular disease, lung cancer, and other respiratory disease. Intervention: The intervention was a 10-week smoking cessation program that included a strong physician message and 12 group sessions using behavior modification and nicotine gum, plus either ipratropium or a placebo inhaler. Results: At 5 years, 21.7% of special intervention participants had stopped smoking since study entry compared with 5.4% of usual care participants. After up to 14.5 years of follow-up, 731 patients died: 33% of lung cancer, 22% of cardiovascular disease, 7.8% of respiratory disease other than cancer, and 2.3% of unknown causes. All-cause mortality was significantly lower in the special intervention group than in the usual care group (8.83 per 1000 person-years vs. 10.38 per 1000 person-years; P = 0.03). The hazard ratio for mortality in the usual care group compared with the special intervention group was 1.18 (95% CI, 1.02 to 1.37). Differences in death rates for both lung cancer and cardiovascular disease were greater when death rates were analyzed by smoking habit. Limitations: Results apply only to individuals with airway obstruction. Conclusion: Smoking cessation intervention programs can have a substantial effect on subsequent mortality, even when successful in a minority of participants.
引用
收藏
页码:233 / 239
页数:7
相关论文
共 24 条
[1]  
[Anonymous], DHHS PUBL
[2]   Hospitalizations and mortality in the Lung Health Study [J].
Anthonisen, NR ;
Connett, JE ;
Enright, PL ;
Manfreda, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (03) :333-339
[3]   Smoking and lung function of lung health study participants after 11 years [J].
Anthonisen, NR ;
Connett, JE ;
Murray, RP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (05) :675-679
[4]   EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].
ANTHONISEN, NR ;
CONNETT, JE ;
KILEY, JP ;
ALTOSE, MD ;
BAILEY, WC ;
BUIST, AS ;
CONWAY, WA ;
ENRIGHT, PL ;
KANNER, RE ;
OHARA, P ;
OWENS, GR ;
SCANLON, PD ;
TASHKIN, DP ;
WISE, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505
[5]   PULMONARY-FUNCTION - RELATION TO AGING, CIGARETTE HABIT, AND MORTALITY - FRAMINGHAM STUDY [J].
ASHLEY, F ;
KANNEL, WB ;
SORLIE, PD ;
MASSON, R .
ANNALS OF INTERNAL MEDICINE, 1975, 82 (06) :739-745
[6]  
CONNETT JE, 1993, CONTROL CLIN TRIALS, V14, pS3
[7]   RISK FACTOR CHANGES AFTER CESSATION OF INTERVENTION IN THE MULTIPLE RISK FACTOR INTERVENTION TRIAL [J].
CUTLER, JA ;
GRANDITS, GA ;
GRIMM, RH ;
THOMAS, HE ;
BILLINGS, JH ;
WRIGHT, NH .
PREVENTIVE MEDICINE, 1991, 20 (02) :183-196
[8]   THE BELGIAN-HEART-DISEASE-PREVENTION-PROJECT - 10-YEAR MORTALITY FOLLOW-UP [J].
DEBACKER, G ;
KORNITZER, M ;
DRAMAIX, M ;
KITTEL, F ;
THILLY, C ;
GRAFFAR, M ;
VUYLSTEEK, K .
EUROPEAN HEART JOURNAL, 1988, 9 (03) :238-242
[9]  
DURKIN DA, 1993, CONTROL CLIN TRIALS, V14, pS20
[10]   OSLO STUDY DIET AND ANTISMOKING TRIAL - RESULTS AFTER 102 MONTHS [J].
HJERMANN, I ;
HOLME, I ;
LEREN, P .
AMERICAN JOURNAL OF MEDICINE, 1986, 80 (2A) :7-11